Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes

Schizophrenia Research

Volumn 130, Issue 1-3, 2011, Pages 238-249

  Katsel, Pavel ^a   Tan, Weilun ^a   Abazyan, Bagrat ^c   Davis, Kenneth L ^a   Ross, Christopher ^c   Pletnikov, Mikhail V ^c   Haroutunian, Vahram ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disrupted in schizophrenia 1; Gene expression; Myelin; Neuregulin; Oligodendrocyte; Oligodendrogenesis; Schizophrenia

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NEU DIFFERENTIATION FACTOR;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FOREBRAIN; GENE EXPRESSION; MOUSE; MUTANT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; DOXYCYCLINE; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PHOSPHORIC DIESTER HYDROLASES; PREGNANCY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RNA, MESSENGER; RNA-BINDING PROTEINS; SOXE TRANSCRIPTION FACTORS; STEM CELLS;

EID: 79960300015     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.04.021     Document Type: Article

References (77)

1. Aberg K., Saetre P., Jareborg N., Jazin E. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7482-7487.
2. Aston C., Jiang L., Sokolov B.P. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J. Neurosci. Res. 2004, 77:858-866.
3. Ayhan Y., Abazyan B., Nomura J., Kim R., Ladenheim B., Krasnova I.N., Sawa A., Margolis R.L., Cadet J.L., Mori S., Vogel M.W., Ross C.A., Pletnikov M.V. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry 2011, 16:293-306.
4. Bahn S., Jones P.B. Gene expression in schizophrenia and bipolar disorder. Schizophr. Res. 2003, 60:60.
5. Barley K., Dracheva S., Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr. Res. 2009, 112:54-64.
6. Bartzokis G., Nuechterlein K.H., Lu P.H., Gitlin M., Rogers S., Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 2003, 53:412-421.
7. Baumann P., West S.C. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem. Sci. 1998, 23:247-251.
8. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., Muir W.J. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 2001, 69:428-433.
9. Brinkmann B.G., Agarwal A., Sereda M.W., Garratt A.N., Muller T., Wende H., Stassart R.M., Nawaz S., Humml C., Velanac V., Radyushkin K., Goebbels S., Fischer T.M., Franklin R.J., Lai C., Ehrenreich H., Birchmeier C., Schwab M.H., Nave K.A. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 2008, 59:581-595.
10. Buchsbaum M.S., Tang C.Y., Peled S., Gudbjartsson H., Lu D., Hazlett E.A., Downhill J., Haznedar M., Fallon J.H., Atlas S.W. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 1998, 9:425-430.
11. Butt A.M., Hornby M.F., Ibrahim M., Kirvell S., Graham A., Berry M. PDGF-alpha receptor and myelin basic protein mRNAs are not coexpressed by oligodendrocytes in vivo: a double in situ hybridization study in the anterior medullary velum of the neonatal rat. Mol. Cell. Neurosci. 1997, 8:311-322.
12. Casaccia-Bonnefil P., Hardy R.J., Teng K.K., Levine J.M., Koff A., Chao M.V. Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 1999, 126:4027-4037.
13. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., Lerch J.P., Trimble K., Uchiyama M., Sakuraba Y., Kaneda H., Shiroishi T., Houslay M.D., Henkelman R.M., Sled J.G., Gondo Y., Porteous D.J., Roder J.C. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007, 54:387-402.
14. Cotter D.R., Pariante C.M., Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 2001, 55:585-595.
15. Devon R.S., Anderson S., Teague P.W., Burgess P., Kipari T.M., Semple C.A., Millar J.K., Muir W.J., Murray V., Pelosi A.J., Blackwood D.H., Porteous D.J. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr. Genet. 2001, 11:71-78.
16. Dracheva S., McGurk S.R., Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J. Neurosci. Res. 2005, 79:868-878.
17. Dracheva S., Davis K.L., Chin B., Woo D.A., Schmeidler J., Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in schizophrenia. Neurobiol. Dis. 2006, 79:157-173.
18. Draetta G., Piwnica-Worms H., Morrison D., Druker B., Roberts T., Beach D. Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate. Nature 1988, 336:738-744.
19. Drerup C.M., Wiora H.M., Topczewski J., Morris J.A. Disc1 regulates foxd3 and sox10 expression, affecting neural crest migration and differentiation. Development 2009, 136:2623-2632.
20. Dugas J.C., Tai Y.C., Speed T.P., Ngai J., Barres B.A. Functional genomic analysis of oligodendrocyte differentiation. J. Neurosci. 2006, 26:10967-10983.
21. Dugas J.C., Ibrahim A., Barres B.A. A crucial role for p57Kip2 in the intracellular timer that controls oligodendrocyte differentiation. J. Neurosci. 2007, 27:6185-6196.
22. Flames N., Long J.E., Garratt A.N., Fischer T.M., Gassmann M., Birchmeier C., Lai C., Rubenstein J.L., Marin O. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 2004, 44:251-261.
23. Flynn S.W., Lang D.J., MacKay A.L., Goghari V., Vavasour I.M., Whittall K.P., Smith G.N., Arango V., Mann J.J., Dwork A.J., Falkai P., Honer W.G. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol. Psychiatry 2003, 8:811-820.
24. Foong J., Maier M., Barker G.J., Brocklehurst S., Miller D.H., Ron M.A. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J. Neurol. Neurosurg. Psychiatry 2000, 68:70-74.
25. Foong J., Symms M.R., Barker G.J., Maier M., Woermann F.G., Miller D.H., Ron M.A. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain 2001, 124:882-892.
26. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, New York.
27. Garratt A.N., Britsch S., Birchmeier C. Neuregulin, a factor with many functions in the life of a schwann cell. Bioessays 2000, 22:987-996.
28. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4746-4751.
29. Hennah W., Thomson P., McQuillin A., Bass N., Loukola A., Anjorin A., Blackwood D., Curtis D., Deary I.J., Harris S.E., Isometsa E.T., Lawrence J., Lonnqvist J., Muir W., Palotie A., Partonen T., Paunio T., Pylkko E., Robinson M., Soronen P., Suominen K., Suvisaari J., Thirumalai S., St C.D., Gurling H., Peltonen L., Porteous D. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol. Psychiatry 2009, 14:865-873.
30. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., Wu D., Xue R., Andrade M., Tankou S., Mori S., Gallagher M., Ishizuka K., Pletnikov M., Kida S., Sawa A. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14501-14506.
31. Hof P.R., Haroutunian V., Friedrich V.L., Byne W., Buitron C., Perl D.P., Davis K.L. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 2003, 53:1075-1085.
32. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama-Shigeno Y., Yoshikawa T., Kato T. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 2005, 25:5376-5381.
33. Katsel P., Davis K.L., Gorman J.M., Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr. Res. 2005, 77:241-252.
34. Katsel P., Davis K.L., Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions: a gene ontology study. Schizophr. Res. 2005, 79:157-173.
35. Katsel P., Davis K.L., Li C., Tan W., Greenstein E., Kleiner Hoffman L.B., Haroutunian V. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology 2008, 33:2993-3009.
36. Kerns D.C., Vong G.S., Barley K., Dracheva S., Katsel P., Casaccia P., Haroutunian V., Byne W. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia. Schizophr. Res. 2010, 120:150-158.
37. Kozar K., Ciemerych M.A., Rebel V.I., Shigematsu H., Zagozdzon A., Sicinska E., Geng Y., Yu Q., Bhattacharya S., Bronson R.T., Akashi K., Sicinski P. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004, 118:477-491.
38. Lim K.O., Hedehus M., Moseley M., de Crespigny A., Sullivan E.V., Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch. Gen. Psychiatry 1999, 56:367-374.
39. Lopez-Bendito G., Cautinat A., Sanchez J.A., Bielle F., Flames N., Garratt A.N., Talmage D.A., Role L.W., Charnay P., Marin O., Garel S. Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell 2006, 125:127-142.
40. Macgregor S., Visscher P.M., Knott S.A., Thomson P., Porteous D.J., Millar J.K., Devon R.S., Blackwood D., Muir W.J. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol. Psychiatry 2004, 9:1083-1090.
41. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., Biechele T., Petryshen T.L., Moon R.T., Haggarty S.J., Tsai L.H. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009, 136:1017-1031.
42. Marta C.B., Davio C., Pasquini L.A., Soto E.F., Pasquini J.M. Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: role of the cytoskeleton and of second messengers. J. Neurosci. Res. 2002, 69:488-496.
43. Martins-de-Souza D. Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J. Psychiatr. Res. 2010, 44:149-156.
44. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 2008, 9:437-452.
45. Meyer K.D., Morris J.A. Immunohistochemical analysis of Disc1 expression in the developing and adult hippocampus. Gene Expr. Patterns 2008, 8:494-501.
46. Michailov G.V., Sereda M.W., Brinkmann B.G., Fischer T.M., Haug B., Birchmeier C., Role L., Lai C., Schwab M.H., Nave K.A. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004, 304:700-703.
47. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000, 9:1415-1423.
48. Millar J.K., Christie S., Anderson S., Lawson D., Hsiao-Wei L.D., Devon R.S., Arveiler B., Muir W.J., Blackwood D.H., Porteous D.J. Genomic structure and localisation within a linkage hotspot of Disrupted in Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol. Psychiatry 2001, 6:173-178.
49. Miller R., Reynolds R. Oligodendroglial lineage. Myelin Biology and Disorders 1 2004, Vol. 1:289-310. Elsevier Academic Press, San Diego, California. R.A. Lazzarini (Ed.).
50. Miskimins R., Srinivasan R., Marin-Husstege M., Miskimins W.K., Casaccia-Bonnefil P. p27(Kip1) enhances myelin basic protein gene promoter activity. J. Neurosci. Res. 2002, 67:100-105.
51. Miyakawa T., Sumiyoshi S., Deshimaru M., Suzuki T., Tomonari H. Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathol. (Berl.) 1972, 20:67-77.
52. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468:244-252.
53. Nguyen L., Borgs L., Vandenbosch R., Mangin J.M., Beukelaers P., Moonen G., Gallo V., Malgrange B., Belachew S. The Yin and Yang of cell cycle progression and differentiation in the oligodendroglial lineage. Ment. Retard. Dev. Disabil. Res. Rev. 2006, 12:85-96.
54. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., Mori S., Moran T.H., Ross C.A. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry 2008, 13(173-86):115.
55. Pringle N.P., Richardson W.D. A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may define the origin of the oligodendrocyte lineage. Development 1993, 117:525-533.
56. Raff M., Apperly J., Kondo T., Tokumoto Y., Tang D. Timing cell-cycle exit and differentiation in oligodendrocyte development. Novartis Found. Symp. 2001, 237:100-107.
57. Rajkowska G., Miguel-Hidalgo J.J., Makkos Z., Meltzer H., Overholser J., Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2002, 57:127-138.
58. Rivers L.E., Young K.M., Rizzi M., Jamen F., Psachoulia K., Wade A., Kessaris N., Richardson W.D. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat. Neurosci. 2008, 11:1392-1401.
59. Scherer S.S., Braun P.E., Grinspan J., Collarini E., Wang D.Y., Kamholz J. Differential regulation of the 2',3'-cyclic nucleotide 3'-phosphodiesterase gene during oligodendrocyte development. Neuron 1994, 12:1363-1375.
60. Schurov I.L., Handford E.J., Brandon N.J., Whiting P.J. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol. Psychiatry 2004, 9:1100-1110.
61. Scott K.L., Plon S.E. CHES1/FOXN3 interacts with ski-interacting protein and acts as a transcriptional repressor. Gene 2005, 359:119-126.
62. Shen S., Lang B., Nakamoto C., Zhang F., Pu J., Kuan S.L., Chatzi C., He S., Mackie I., Brandon N.J., Marquis K.L., Day M., Hurko O., McCaig C.D., Riedel G., St C.D. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J. Neurosci. 2008, 28:10893-10904.
63. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., Evans H.J. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336:13-16.
64. Stark A.K., Uylings H.B., Sanz-Arigita E., Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatry 2004, 161:882-888.
65. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
66. Stolt C.C., Rehberg S., Ader M., Lommes P., Riethmacher D., Schachner M., Bartsch U., Wegner M. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 2002, 16:165-170.
67. Stritt C., Stern S., Harting K., Manke T., Sinske D., Schwarz H., Vingron M., Nordheim A., Knoll B. Paracrine control of oligodendrocyte differentiation by SRF-directed neuronal gene expression. Nat. Neurosci. 2009, 12:418-427.
68. Suh H.W., Lee H.K., Seo Y.J., Kwon M.S., Shim E.J., Lee J.Y., Choi S.S., Lee J.H. Kainic acid (KA)-induced Ca2+/calmodulin-dependent protein kinase II (CaMK II) expression in the neurons, astrocytes and microglia of the mouse hippocampal CA3 region, and the phosphorylated CaMK II only in the hippocampal neurons. Neurosci. Lett. 2005, 381:223-227.
69. Taveggia C., Zanazzi G., Petrylak A., Yano H., Rosenbluth J., Einheber S., Xu X., Esper R.M., Loeb J.A., Shrager P., Chao M.V., Falls D.L., Role L., Salzer J.L. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 2005, 47:681-694.
70. Taveggia C., Thaker P., Petrylak A., Caporaso G.L., Toews A., Falls D.L., Einheber S., Salzer J.L. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia 2008, 56:284-293.
71. Tekki-Kessaris N., Woodruff R., Hall A.C., Gaffield W., Kimura S., Stiles C.D., Rowitch D.H., Richardson W.D. Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon. Development 2001, 128:2545-2554.
72. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
73. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., Rachmanova V. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 2001, 55:597-610.
74. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004, 67:269-275.
75. Vostrikov V.M., Uranova N.A., Orlovskaya D.D. Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr. Res. 2007, 94:273-280.
76. Wood J.D., Bonath F., Kumar S., Ross C.A., Cunliffe V.T. Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Hum. Mol. Genet. 2009, 18:391-404.
77. Zeman W., Innes J.R.M. Craigie's Neuroanatomy of the Rat 1963, Academic Press, New York.